Scott Gottlieb, MD, discusses the real-world outcomes of tildrakizumab for moderate to severe plaque psoriasis.
Psoriasis is a chronic skin condition that causes patches of dry, itchy skin, called plaques. Without proper treatment plaques can get itchy and flaky and then sometimes crack and bleed. People with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results